Nyheter
The Only ETF Targeting Generics
Why Market Vectors® Generic Drugs ETF (GNRX), The Only ETF Targeting Generics?
Industry may benefit from ongoing push to lower health care costs
The only ETF offering global exposure to generic drug producers
Positioned to take advantage of the expected growth of biosimilars
• Approximately 60%1 of Americans take prescription drugs — 88%2 of these are generics
• Generics are shaping the future of pharma as demand continues to soar
• GNRX is the only ETF that gives investors access to the global generics industry
Market Vectors® Generic Drugs ETF (GNRX) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics & New Pharma Index (IGNRXT), which is intended to track the overall performance of companies that derive a significant proportion of their revenues or that have the potential to derive a significant proportion of their revenues from the generic drug industry, or that have a primary business focus on the generic drug industry.
click to enlarge
click to enlarge
Access Affordable Pharma
Across the globe more people than ever are taking prescription drugs, contributing to the rising costs of health care. Consumers, insurance companies, and governments are helping to fuel the growth of the generic drug industry as it often provides them with a lower cost alternative to brand name pharmaceuticals. Generics account for 88% of all prescriptions in the U.S.1, 55% in the EU2, and 47% in Japan3. With the Market Vectors Generic Drugs ETF (GNRX) investors can specifically target global generics manufacturers in their investment portfolios.
Generics Are Filling Medicine Cabinets Across the U.S.
click to enlarge
For illustrative purposes only. Percentages are approximations. Source: The Journal of American Medical Association, November 3, 2015. Generic Pharmaceutical Association 2015 Annual Savings Report.
Access Affordable Pharma
Generics account for 88% of prescriptions in the U.S. and 55% of prescriptions in the EU1.
Spending on pharmaceuticals worldwide is expected to increase to $1.3 trillion by 2018, 52% of this increase is expected to come from generics2. Global population growth, an aging demographic, and improved access to healthcare are expected to drive growth in both developed and emerging markets. Segment of Generic Prescriptions in the U.S.1
Over the past 10 years generic drug prescriptons in the U.S. have increased ~54%
click to enlarge
Recently generic drug makers have seen increased investor interest as many brand name drug makers lost patent protections (the “patent cliff”). The next stage of growth is expected to come from hard-to-copy biosimilars, biobetters and supergenerics as government policymakers and insurers continue to seek lower cost drug options for consumers.
Generics Defining the Future of Pharma
Increased global pharmaceutical spending and the drive for lower health care costs have supported demand for generics. Generic drug makers may also see new revenue opportunities from expiring patents on branded drugs and from new classes of generics, such as biosimilars, which provide the potential for higher margins.
Investment Case
The Only ETF Targeting Generics
Market Vectors Generic Drugs ETF (GNRX) is the only ETF specifically targeting the generic drug space by seeking to track an index of global generic drug manufacturers.
GNRX Details
Why GNRX?
• Approximately 60%1 of Americans take prescription drugs — 88%2 of these are generics
• Generics are shaping the future of pharma as demand continues to soar
• GNRX is the only ETF that gives investors access to the global generics industry
Introduction to Generics and Biosimilars
IMPORTANT DISCLOSURES
An investment in the Fund may be subject to risks which include, among others, the development, protection and exploitation of intellectual property rights, expiration of patents and inability to enforce intellectual property rights, significant costs associated with research and development and speculation that those investments will result in profitable products, arduous regulatory approval processes, rapid and significant technological change, uncertainty of reimbursement status by third-party payers such as Medicare, Medicaid, and private health insurance plans. Foreign and emerging markets investments are subject to risks, which include changes in economic and political conditions, foreign currency fluctuations, changes in foreign regulations, changes in currency exchange rates, unstable governments, and limited trading capacity which may make these investments volatile in price or difficult to trade. Medium-capitalization companies may be subject to elevated risks. The Fund’s assets may be concentrated in a particular sector and may be subject to more risk than investments in a diverse group of sectors.
Indxx Global Generics & New Pharma Index (the ”Index”) is the exclusive property of Indxx, LLC. Indxx, LLC uses its best efforts to ensure that the Index is calculated correctly. Indxx, LLC has no obligation to point out errors in the Index to third parties. Market Vectors Generic Drugs ETF is not sponsored, endorsed, sold or promoted by Indxx, LLC and Indxx, LLC makes no representation regarding the advisability of investing in Market Vectors Generic Drugs ETF.
Fund shares are not individually redeemable and will be issued and redeemed at their ”Net Asset Value” (NAV) only through certain authorized broker-dealers in large, specified blocks of shares called creation units and otherwise can be bought and sold only through exchange trading. Creation units are issued and redeemed principally in kind. Shares may trade at a premium or discount to their NAV in the secondary market.
Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of the Fund carefully before investing. To obtain a prospectus and summary prospectus, which contains this and other information call 800.826.2333 or visit http://www.vaneck.com/market-vectors. Please read the prospectus and summary prospectus carefully before investing.
Van Eck Securities Corporation
666 Third Avenue
New York, NY 10017
800.826.2333
This message is intended only for the personal and confidential use of the designated recipient. If you are not the intended recipient of this message you are hereby notified that any review, dissemination, distribution, or copying of this message is strictly prohibited. This communication is for informational purposes only and should not be regarded as an offer to sell or as a solicitation of an offer to buy any financial product, an official confirmation of any transaction, or as an official statement of Van Eck Global or any of its subsidiaries. Email transmissions cannot be guaranteed to be secure or error-free. Therefore we do not represent that this information is complete or accurate and it should not be relied upon as such. All information is subject to change without notice. All emails at Van Eck Global are, in accordance with Firm policy, to be used for Van Eck Global’s business purposes only. Emails sent from or to the Firm are subject to review by the Firm in accordance with the Firm’s procedure for the review of correspondence.
© Van Eck Global. All rights reserved
Donald Trump’s return to the White House has forced European leaders to reconsider their defence capabilities. Trump’s administration has stated that it expects European countries to take on a greater role in their own security, as well as giving overt signals that it has less interest in the future of the continent’s security. In a worst-case scenario, there are growing fears about the US’ continued commitment to the NATO alliance. This article will outline the scale of the task ahead for Europe to prepare for a world where it can potentially no longer rely on the US for its security.
Europe alone?
First, it is worth noting that the prospect of a US pullout of NATO remains unlikely. While members of Trump’s cabinet have endorsed a withdrawal, the president himself has not. Key members of Trump’s cabinet such as Secretary of State Marco Rubio appear to remain strong believers in the alliance. Crucially, in 2023, the US Congress passed a law requiring a two-thirds majority vote before any President can withdraw from the alliance. Given the current makeup of Congress, such a vote passing seems unlikely.
However, European leaders are taking the risk seriously. Even if the worst-case scenario of a total US withdrawal from NATO does not come to pass, the prospect can no longer be discounted. At the same time, even if the US continues as a member, there is a growing expectation of Europe to develop its own defence capabilities. There is, therefore, a renewed sense among European leaders that they must develop credible security deterrence in the absence of the US.
What is needed?
A recent analysis by Bruegel and the Kiel Institute for the World Economy provides insights into the measures Europe would need to undertake to deter potential aggression from Russia in the absence of US support. [1]
First, soldiers. Currently, the US has around 100,000 troops stationed on the continent, with NATO military planners assuming an additional 200,000 would be rapidly dispatched to Europe in the event of conflict.
A theoretical absence of US support, therefore, means considering how Europe may replace these 300,000 soldiers. Europe, including the UK, currently has almost 1.5 million active-duty military personnel. In theory, this makes replacing the 300,000 US troops easy enough. However, as analysis by Bruegel notes: “The combat power of 300,000 US troops is substantially greater than the equivalent number of European troops distributed over 29 national armies.”
A crucial weakness of European troops will be fragmentation. A Europe without US support, therefore, is faced with two choices: replace the 300,000 with substantially more soldiers – to offset the fragmented weakness – or rapidly enhance cooperation.
The challenge is also stark when it comes to equipment. The Bruegel analysis claims that preventing a rapid Russian breakthrough in the Baltic states would, at a minimum, require “1,400 tanks, 2,000 infantry fighting vehicles and 700 artillery pieces (155mm howitzers and multiple rocket launchers)”. To put this into perspective, that is more firepower than the French, German, Italian, and British land forces combined. And that is just for providing a credible deterrence in the Baltic states.
European states will also have to invest substantially in developing their own transport, missile, drone, communications, and intelligence capabilities.
Historic underspend
Future-proofing European defence against a potential absence of US support, therefore, is a tremendous task. Achieving anything approaching what is needed to shore up the continent’s defence will cost tremendous sums.
This has been made harder by the underspending on defence among European NATO members over the past few decades. The euphoria of the post-Cold War era saw European governments slash their defence spending. Money that had previously been spent on military security could be reallocated to spending on social security.
With Russia’s first invasion of Ukraine in 2014, NATO took steps to reverse this, principally by setting a defence spending target of 2% of GDP for members. But very few NATO members actually reached this target. As late as 2021, just 6 members of NATO spent 2% or more on defence.
However, as the graph below shows, the number of NATO members hitting the 2% target has rapidly ramped up, with 23 members now hitting the 2% target.
Source: NATO, June 2024. Data excludes the U.S. For illustrative purposes only. Chart displays expected data.
Yet the historic underspending by Europe leaves a hole in European defence capabilities. Figures from Exante Data shows that the cumulative underspend since 2014, relative to the 2% targets, among European NATO members equals €850bn. [2]
The road to 5%
The task for both readying Europe for defence challenges in a world without US support, as well as addressing the historic underfunding of European defence, will require defence spending rising significantly above 2% of GDP.
Currently, European (and Canada) NATO members spend, on average, around 2% of GDP on defence. If NATO ex-USA members were to increase defence spending to 5% of GDP, what would this look like? If certain assumptions are made, we can map out the bullish and bearish scenarios for NATO defence spending.
In our bull case scenario, we assume NATO ex-US defence budgets to increase to 5% of GDP by 2029, while assuming equipment spending as % of total NATO budget growing by 1% per year. It also includes assumptions of GDP growth per year standing at 2%.
In this scenario, equipment expenditure would increase by $350billion, over half the total revenue generated by defence companies in 2023.
Meanwhile, in our bear case scenario, equipment expenditure still grows by almost $100billion over the period. This bear case scenario assumes NATO ex-US defence budgets grow to 3.5% by 2029, with equipment expenditure remaining steady as a percentage of defence spending (31.6%) and GDP growth of 1% per year. This would see additional equipment expenditure increase by $92billion.
Source: NATO, HANetf analysis. Charts display projected data. For illustrative purposes only. Additional sources available upon request.
The Future of Defence
While the complete withdrawal of the US from NATO is a hypothetical scenario, these estimates underscore the significant investments and structural changes Europe would need to implement to maintain a credible defence posture independently.
Future of Defence UCITS ETF (ASWC) seeks to provide exposure to the companies generating revenue from NATO and NATO+ ally defence and cyber defence spending. The “NATO screen” seeks to align with the values of investors who may have concerns about defence investing, but cannot ignore the current political climate, and therefore seek a smarter and more considered approach.
NATO is a defensive alliance and itself states that “deterrence and defence is one of its core tasks” – focusing on companies operating in NATO allied countries limits the possibility of constituents of the ETF being companies operating in countries that could one day be adversaries to the alliance.
Key Risks
• Thematic ETFs are exposed to a limited number of sectors and thus the investment will be concentrated and may experience high volatility.
• Investors’ capital is fully at risk and may not get back the amount originally invested.
• Exchange rates can have a positive or negative effect on returns.
• For a complete overview of all the risks, please refer to the “Risk Factors” in the Prospectus.
Handla ASWC ETF
HANetf Future of Defence UCITS ETF (ASWC ETF) är en europeisk börshandlad fond. Denna fond handlas på flera olika börser, till exempel Deutsche Boerse Xetra och London Stock Exchange. Av den anledningen förekommer olika kortnamn på samma börshandlade fond.
Det betyder att det går att handla andelar i denna ETF genom de flesta svenska banker och Internetmäklare, till exempel DEGIRO, Nordnet, SAVR och Avanza.
Krypto-ETN från 21Shares ger tillgång till både Bitcoin och Ethereum
WGRU ETF köper kvalitativa utdelningsaktier
A hypothetical U.S. withdrawal from NATO
FTGA ETF satsar på den globala flygindustrin och försvarssektorn
Virtune XRP ETP når1,1 miljarder kronor i förvaltat kapital
MONTDIV ETF är Sveriges första månadsutdelande ETF
Varför investera i indexfonder?
100 gånger pengarna, aktier som gör 10 000 kronor till 1 miljon
Montrose lanserar Sveriges första månadsutdelande ETF
BlackRock lanserar aktivt förvaltad Fixed Income UCITS ETF
-
Nyheter3 veckor sedanMONTDIV ETF är Sveriges första månadsutdelande ETF
-
Nyheter4 veckor sedanVarför investera i indexfonder?
-
Nyheter2 veckor sedan100 gånger pengarna, aktier som gör 10 000 kronor till 1 miljon
-
Nyheter3 veckor sedanMontrose lanserar Sveriges första månadsutdelande ETF
-
Nyheter3 veckor sedanBlackRock lanserar aktivt förvaltad Fixed Income UCITS ETF
-
Nyheter2 veckor sedanInvesterarnas intresse kraftigt förändrat under februari 2025
-
Nyheter4 veckor sedanSprotts Steve Schoffstall om kärnenergitrender, uranmarknaden och politiska effekter
-
Nyheter3 veckor sedanNATO-anpassade Future of Defense ETF når en miljard USD i AUM
